|
SMARCD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.215290E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.858000E-03 |
| Normal-vs-Stage2 |
6.160200E-03 |
| Normal-vs-Stage3 |
1.059880E-02 |
| Normal-vs-Stage4 |
4.995400E-04 |
| Stage1-vs-Stage2 |
1.893550E-01 |
| Stage1-vs-Stage3 |
9.298400E-01 |
| Stage1-vs-Stage4 |
1.020620E-01 |
| Stage2-vs-Stage3 |
2.684200E-01 |
| Stage2-vs-Stage4 |
8.593800E-01 |
| Stage3-vs-Stage4 |
9.509700E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.502140E-03 |
| Normal-vs-AfricanAmerican |
5.240400E-02 |
| Normal-vs-Asian |
4.768300E-02 |
| Caucasian-vs-AfricanAmerican |
9.709200E-01 |
| Caucasian-vs-Asian |
3.523400E-01 |
| AfricanAmerican-vs-Asian |
5.991800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.231970E-02 |
| Normal-vs-Female |
1.284000E-03 |
| Male-vs-Female |
7.387000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.858000E-02 |
| Normal-vs-Age(41-60Yrs) |
9.600900E-04 |
| Normal-vs-Age(61-80Yrs) |
3.224800E-03 |
| Normal-vs-Age(81-100Yrs) |
7.048400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.922800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.022400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.774400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.501800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.179000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.768000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.533600E-01 |
| Classical-VS-Follicular |
5.047800E-01 |
| Classical-VS-Other |
2.863600E-01 |
| Classical-VS-Normal |
1.437680E-03 |
| Tall-VS-Follicular |
5.083600E-01 |
| Tall-VS-Other |
2.104200E-01 |
| Tall-VS-Normal |
7.603400E-03 |
| Follicular-VS-Other |
5.808200E-01 |
| Follicular-VS-Normal |
5.199600E-02 |
| Other-VS-Normal |
7.942200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.464800E-03 |
| Normal-vs-N1 |
6.756600E-01 |
| N0-vs-N1 |
5.447800E-02 |
|
|
